GlassScriptPhysician profile
Alan S Helfman
NPI 1982610879
$2,896.58
in general payments reported to CMS, 2019-2025
22 companies · $51.27 in 2025
The $51.27 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,555 · 2020: $583 · 2021: $654 · 2022: $54.03 · 2025: $51.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $668.85 | 2019-2021 | |
| Astellas Pharma US INC | $307.91 | 2019-2021 | |
| Coloplast Corp | $251.88 | 2019-2025 | |
| Pfizer INC. | $248.72 | 2019-2020 | |
| Antares Pharma, INC. | $192.24 | 2019-2021 | |
| Clarus Therapeutics INC. | $169.66 | 2021 | |
| Neotract INC. | $161.41 | 2019 | |
| Endo Pharmaceuticals INC. | $135.40 | 2019-2021 | |
| Abbvie INC. | $127.37 | 2019-2021 | |
| Procept Biorobotics Corporation | $122.00 | 2019-2020 | |
| Blue Earth Diagnostics | $97.58 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $80.98 | 2019-2021 | |
| Allergan, INC. | $70.21 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.24 | 2020-2021 | |
| Myovant Sciences INC. | $40.29 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $33.80 | 2019 | |
| Dendreon Pharmaceuticals LLC | $33.03 | 2019-2021 | |
| 180 Medical, INC. | $27.38 | 2019 | |
| Myriad Genetic Laboratories, INC. | $20.40 | 2021 | |
| Boston Scientific Corporation | $19.69 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.65 | 2019 | |
| Amgen INC. | $13.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Helfman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.